Serum levels of tumor necrosis factor alpha in patients treated with granulocyte-macrophage colony-stimulating factor.
Stehle
B
B
Weiss
C
C
Ho
A D
AD
Hunstein
W
W
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003115:Colony-Stimulating Factors / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008942:Mitoxantrone / Q000008:administration & dosage; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
D003115:Colony-Stimulating Factors; D006133:Growth Substances; D014409:Tumor Necrosis Factor-alpha; D003561:Cytarabine; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D008942:Mitoxantrone